NA

Nikita Abhishek Nayak

Active Director Director DIN 09593334
DIN 09593334 First appointment May 2022
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2022
Shareholding value •••• Premium profile

About Nikita Abhishek Nayak

Data last updated:

Nikita Abhishek Nayak is a Director at Sc Pharmachem Private Limited (since 2022). Sc Pharmachem Private Limited reported revenue of ₹32.36 Cr (FY 2025).

DIN 09593334
Primary Designation Director
First Appointment 04 May 2022
Oldest Company Age 4 yrs
Largest company Sc Pharmachem Private Limited · ₹32.36 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sc Pharmachem Private Limited U59131MH2022PTC379760
Director04 May 20222022₹32.36 Cr (FY 2025)Active

Board colleagues of Nikita Abhishek Nayak

Directorship timeline

Open interactive timeline →
Sc Pharmachem Private Limited
Premium access

Shareholding and investment profile for Nikita Abhishek Nayak

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nikita Abhishek Nayak

Nikita Abhishek Nayak currently holds 1 directorship: Sc Pharmachem Private Limited (Director, since 04 May 2022, revenue ₹32.36 Cr (FY 2025)).

Nikita Abhishek Nayak was first appointed on 04 May 2022 as Director at Sc Pharmachem Private Limited.

The current boards of Nikita Abhishek Nayak's companies include Abhishek Sunil Nayak (Sc Pharmachem Private Limited), Sheela Sunil Nayak (Sc Pharmachem Private Limited), Sunil Vishwanath Nayak (Sc Pharmachem Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available